SCHEMBL1028620

SCHEMBL1028620

C[C@@H]1CCC[N]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1032379 1.00
SCHEMBL27511 1.00
SCHEMBL43289 0.90
SCHEMBL1029951 0.90
SCHEMBL1032016 0.90
SCHEMBL6401645 0.88
SCHEMBL1547797 0.88
SCHEMBL1033660 0.78
SCHEMBL1032060 0.78
SCHEMBL154214 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024046323-A1 BENZO FIVE-MEMBERED NITROGEN RING COMPOUNDS, PREPARATION METHOD THEREFOR, AND MEDICAL USES THEREOF 山东大学 2024-03-07 WO claimed
CN-117143039-A Benzo five-membered nitrogen ring compound, preparation method and medical application thereof 山东大学 2023-12-01 CN claimed
EP-2852584-B1 SUBSTITUTED DIPYRIDYLAMINES AND USES THEREOF HOFFMANN LA ROCHE (CH) 2018-02-28 EP claimed
EP-2852584-A1 SUBSTITUTED DIPYRIDYLAMINES AND USES THEREOF F. Hoffmann-La Roche AG (CH) 2015-04-01 EP claimed
US-8969552-B2 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor AbbVie Deutschland GmbH & Co. KG (DE) 2015-03-03 US claimed
EP-2439203-B1 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor ABBVIE DEUTSCHLAND (DE) 2014-11-19 EP claimed
WO-2013174780-A1 SUBSTITUTED DIPYRIDYLAMINES AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2013-11-28 WO claimed
EP-1812416-B1 ARYLSULFONYLMETHYL OR ARYLSULFONAMIDE SUBSTITUTED AROMATIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR ABBOTT GMBH & CO KG (DE) 2013-08-21 EP claimed
US-8486984-B2 Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor ABBOTT GMBH & CO., KG (DE) 2013-07-16 US claimed
US-8383641-B2 Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor ABBOTT GMBH & CO. KG (DE) 2013-02-26 US claimed
US-20050192277-A1 Novel amines as histamine-3 receptor ligands and their therapeutic applications ABBVIE INC. 2005-09-01 US claimed
US-20050054677-A1 Process for preparing amine-substituted benzofurans KU YI-YIN (US) 2005-03-10 US claimed
US-6822101-B2 REACTING 1-(3-BUTYNYL)-PYRROLIDINE OR -PIPERIDINE WITH PHENOLIC COMPOUND; CYCLIZATION; TREATING WITH BORONIC ACID DERIVATIVE; HISTAMINE-3 RECEPTOR LIGANDS ABBOTT LABORATORIES 2004-11-23 US claimed
US-20040133007-A1 Process for preparing amine-substituted benzofurans ABBOTT LABORATORIES 2004-07-08 US claimed
WO-2004024707-A2 PROCESS FOR PREPARING AMINE TYPE SUBSTITUTED BENZOFURANS ABBOTT LABORATORIES (US) 2004-03-25 WO claimed
US-20040054185-A1 Process for preparing amine-substituted benzofurans COWART MARLON D (US) 2004-03-18 US claimed
EP-1370546-A2 NOVEL AMINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS Abbott Laboratories (US) 2003-12-17 EP claimed
US-20020183309-A1 Novel amines as histamine-3 receptor ligands and their therapeutic applications ABBOTT LABORATORIES 2002-12-05 US claimed
US-20020169188-A1 Novel amines as histamine-3 receptor ligands and their therapeutic applications ABBVIE INC. 2002-11-14 US claimed
WO-2002074758-A2 NOVEL AMINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS ABBOTT LABORATORIES (US) 2002-09-26 WO claimed